Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
BMC Oral Health ; 23(1): 878, 2023 11 17.
Article in English | MEDLINE | ID: mdl-37978362

ABSTRACT

BACKGROUND: N6-methyladenosine (m6A) RNA modification regulators play an important role in many human diseases, and its abnormal expression can lead to the occurrence and development of diseases. However, their significance in pulpitis remains largely unknown. Here, we sought to identify and validate the m6A RNA regulatory network in pulpitis. METHODS: Gene expression data for m6A regulators in human pulpitis and normal pulp tissues from public GEO databases were analyzed. Bioinformatics analysis including Gene ontology (GO) functional, and Kyoto encyclopedia of genes and genomes (KEGG) pathway analyses were performed by R package, and Cytoscape software was used to study the role of m6A miRNA-mRNA regulatory network in pulpitis. Quantitative real-time PCR (qRT-PCR) was performed to validate the expression of key m6A regulators in collected human pulpitis specimens. RESULTS: Differential genes between pulpitis and normal groups were found from the GEO database, and further analysis found that there were significant differences in the m6A modification-related genes ALKBH5, METTL14, METTL3, METTL16, RBM15B and YTHDF1. And their interaction relationships and hub genes were determined. The hub m6A regulator targets were enriched in immune cells differentiation, glutamatergic synapse, ephrin receptor binding and osteoclast differentiation in pulpitis. Validation by qRT-PCR showed that the expression of methylases METTL14 and METTL3 was decreased, thus these two genes may play a key role in pulpitis. CONCLUSION: Our study identified and validated the m6A RNA regulatory network in pulpitis. These findings will provide valuable resource to guide the mechanistic and therapeutic analysis of the role of key m6A modulators in pulpitis.


Subject(s)
MicroRNAs , Pulpitis , Humans , Pulpitis/genetics , RNA, Messenger/genetics , Dental Pulp , Computational Biology , Methyltransferases/genetics
2.
Int J Rheum Dis ; 26(6): 1137-1142, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36691304

ABSTRACT

Anti-MDA5 antibody dermatomyositis (DM) is a special type of myositis, which can potentially cause rapidly progressive interstitial lung disease (RP-ILD). Mixed connective tissue disease (MCTD) is a complex disease with different characteristics of autoimmune connective tissue disease, associated with ILD. Both are rare diseases, and few patients with both diseases have been reported. A 71-year-old woman complained of palpitations, with a 2 months history of rash around her hands, extensor surface of right elbow, and the nape of her neck. Subsequently, the patient had acute exacerbation of dyspnea and tachypnea. Anti-Ro52, U1 RNP and MDA5 antibodies were positive; the presenting evidence was suggestive of anti-MDA5+ DM-RP-ILD complicated with MCTD. Our patient deteriorated rapidly and had a fatal outcome, despite "triple therapy" for RP-ILD. This case illustrates that patients with coexisting anti-MDA5+ DM and MCTD have the former's typical clinical manifestations, and may develop ILD quickly rather than slowly as in MCTD, especially with the coexistence of anti-Ro52 antibodies.


Subject(s)
Autoimmune Diseases , Dermatomyositis , Lung Diseases, Interstitial , Mixed Connective Tissue Disease , Humans , Female , Aged , Mixed Connective Tissue Disease/complications , Autoantibodies , Autoimmune Diseases/complications , Retrospective Studies
4.
Environ Sci Pollut Res Int ; 28(46): 65363-65373, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34235682

ABSTRACT

In the process of coal gangue surface accumulation and underground filling disposal, the heavy metals contained in coal gangue will inevitably precipitate out and migrate, which will cause serious environmental pollution. Seventy-five gangue samples of different geological ages are obtained from 25 coal mines in China. The contents of Hg, Pb, Cd, Cr, As, Cu, Zn, Mn, Se, and Be in gangue samples are determined. The enrichment coefficients of heavy metal elements in coal gangue are analyzed. The formation of heavy metal elements in gangue is studied by cluster analysis and principal component analysis. The results showed that the contents of Pb, Se, and As in gangue samples formed in Late Carboniferous and Early Permian are highest; the contents of Cr, Cd, Be, Cu, and Zn in gangue samples formed in Late Permian are highest. The later the formation age of coal gangue, the lower the overall enrichment of heavy metal elements. The contents of Cu, Be, Cd, Zn, and Cr in coal gangue are mainly controlled by sedimentation. The contents of Pb and Se are mainly affected by the affinity between heavy metal elements in coal gangue. The affinity between Mn and other heavy metal elements is weak, and sulfur had a certain influence on the content of Mn.


Subject(s)
Metals, Heavy , Soil Pollutants , China , Coal/analysis , Environmental Monitoring , Environmental Pollution , Metals, Heavy/analysis , Risk Assessment , Soil Pollutants/analysis
5.
Sci Rep ; 11(1): 14790, 2021 07 20.
Article in English | MEDLINE | ID: mdl-34285322

ABSTRACT

The appeal to enroll patients with primary breast and lung cancer in clinical trials is increasing, but survival of these two primary cancers remains to be elucidated. This study analyzed the prognosis of primary breast duct carcinoma with subsequent lung adenocarcinoma (BCLA) and primary breast duct carcinoma with prior lung adenocarcinoma (LABC). Cohorts of 3,515 patients with BCLA and 654 patients with LABC were identified from the Surveillance, Epidemiology, and End Results database. Patients were classified into simultaneous two primary cancer (sTPC), metachronous two primary cancer (mTPC1), or mTPC2 groups when the interval times between breast and lung cancer were within 6 months, between 7 and 60 months, or over 60 months, respectively. The propensity score matching program (PSM) was applied to determine the survival of BCLA/LABC relative to single breast/lung cancer. Cox proportional hazard regression model and competing risk modes were performed to identify confounders associated with all-cause and cancer-specific death, respectively. Survival of patients with LABC/BCLA relative to single breast/lung cancer was accessed via median survival time. The survival of patients with BCLA/LABC was generally poor compared with the survival of those with single breast cancer. The PSM-estimated HR in the sTPC group with BCLA and in the mTPC1 and mTPC2 groups with LABC were 0.75 (95% CI 0.62-0.90), 0.52 (95% CI 0.27-0.98), and 0.36 (95% CI 0.20-0.65), respectively, whereas the SHRs were 0.80 (95% CI 0.66-0.97), 0.68 (95% CI 0.34-1.34), and 0.46 (95% CI 0.27-0.80), respectively, compared with those in the single lung cancer group. By contrast, the survival rates of the remaining patients did not differ. The median survival times since secondary malignancy were 42, 23, and 20 months in the sTPC, mTPC1, and mTPC2 groups with BCLA, respectively, and 18, 60, and 180 months in those with LABC, respectively. For patients with BCLA, the adjusted Cox regression suggested incidences of all-cause deaths in mTPC1group were statically higher than those in sTPC group, whereas the incidences of all-cause and cancer-specific death in the mTPC1 and mTPC2 groups were statistically lower than those in the sTPC group. The prognosis of patients with breast cancer and subsequent lung cancer of over 18 months was not significantly different than that of single lung cancer, which supported the profound appeal to increase the involvement of these two primary cancers in potential beneficial clinical trials. For patients with lung cancer and prior breast cancer of within 6 months and subsequent breast cancer of over 18 months, prognosis was improved relative to single lung cancer. Therefore, additional attention is needed to eliminate the potential bias may when these patients are recruited in the clinical trials.


Subject(s)
Adenocarcinoma of Lung/mortality , Breast Neoplasms/mortality , Carcinoma, Ductal, Breast/mortality , Lung Neoplasms/mortality , Neoplasms, Second Primary/mortality , Aged , Female , Humans , Incidence , Male , Middle Aged , Prognosis , Propensity Score , SEER Program , Survival Analysis
6.
Article in English | MEDLINE | ID: mdl-32082261

ABSTRACT

Hyperbaric oxygen (HBO) therapy is a treatment modality useful for diseases. Hypoxia could stimulate the induction of insulin resistance. Therefore, we sought to determine whether hyperbaric oxygen would ameliorate insulin sensitivity by promoting glucose transporter type 4 (GLUT4) expression in muscle and by stimulating UCP1 in brown adipose tissue (BAT) in a streptozocin (STZ)-induced type 2 diabetes mellitus (T2DM) mouse model. Male C57BL/6J mice were treated three times with low-dose of streptozocin (60 mg/kg, i.p.) and were fed with high-fat diets (HFD) to establish the T2DM model. HBO was administered daily as 100% oxygen at 2.0 atmosphere absolute (ATA) for 1 h for a week. We found that HBO significantly reduced blood glucose levels and attenuated insulin resistance in T2DM mice. HBO modulated food intake by influencing the activity of neuropeptide Y (NPY)-positive neurons in the arcuate nucleus (Arc). HBO treatment increased GLUT4 amount and level of phosphorylated Akt (p-Akt) in muscles of T2DM mice whereas this treatment stimulated the phosphorylation of AMPK in muscles of both T2DM and HFD mice. The morphological staining of BAT and the increased expression of uncoupling of protein 1 (UCP1) demonstrated the promotion of metabolism after HBO treatment. These findings suggest that HBO ameliorates insulin sensitivity of T2DM mice by stimulating the Akt signaling pathway and by promoting GLUT4 expression in muscle, and by increasing UCP1 expression in BAT.


Subject(s)
Adipose Tissue, Brown/metabolism , Diabetes Mellitus, Type 2/therapy , Glucose Transporter Type 4/genetics , Hyperbaric Oxygenation , Insulin Resistance/genetics , Muscle, Skeletal/metabolism , Uncoupling Protein 1/metabolism , Animals , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/metabolism , Glucose Transporter Type 4/metabolism , Insulin Resistance/physiology , Male , Mice , Mice, Inbred C57BL , Oxygen/metabolism , Signal Transduction/genetics
7.
J Endod ; 45(12): 1496-1503, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31623908

ABSTRACT

INTRODUCTION: Cyclophilin A (CypA) is a cytosolic protein involved in multiple biological functions, such as inflammation, tissue remodeling, tumorigenesis, and vascular diseases. Human periapical lesions are induced by bacterial infections. However, the expression of CypA in human periapical lesions remains unclear. This study aimed to investigate the presence of CypA in human periapical lesions and the possible association of CypA with angiogenesis, inflammatory cell infiltration, and alveolar bone degradation during inflammatory development. METHODS: Fifty-eight human periapical tissues, including periapical granulomas (PGs, n = 28), radicular cysts (RCs, n = 24), and healthy control tissues (control group, n = 6) were collected. Samples were fixed and analyzed. CypA expression was detected and analyzed by immunohistochemistry in different cross sections. Double immunofluorescence was assessed to colocalize CypA with CD34, CypA with matrix metalloproteinase 9 (MMP-9), and CD147 with MMP-9. RESULTS: CypA was significantly overexpressed in the RC and PG groups compared with the control group (P < .05), but the difference between the RC and PG groups was insignificant (P > .05). CypA-positive cells were mainly lymphocytes, endothelial cells, epithelial cells, and plasma cells. The double-labeling analysis of CypA with CD34 suggested that CypA expression was associated with angiogenesis during periapical lesions. MMP-9 colocalized with both CypA and CD147 indicated that CypA may colocalize with CD147 and may be associated with the degradation of soft and hard tissues around human periapical lesions. CONCLUSIONS: CypA may be involved in the development of periapical lesions with an increase in inflammatory cell infiltration, angiogenesis acceleration, and alveolar bone degradation.


Subject(s)
Cyclophilin A , Periapical Granuloma , Radicular Cyst , Case-Control Studies , Cyclophilin A/metabolism , Endothelial Cells , Humans , Inflammation , Matrix Metalloproteinase 9 , Periapical Granuloma/metabolism , Radicular Cyst/metabolism
8.
J Endod ; 44(8): 1276-1282, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29935870

ABSTRACT

INTRODUCTION: Interferon regulatory factor 8 (IRF8) is a critical transcription factor in innate immune responses that regulates the development and function of myeloid cells. Human periapical lesions are caused by endodontic microbial infections. However, the presence of IRF8 in human periapical lesions remains elusive. This study aims to explore the expression of IRF8 in human periapical lesions and the possible association of IRF8 with macrophages, nuclear factor kappa B (NF-κB) signaling, and the autophagy process. METHODS: Thirty-nine human periapical tissues, including healthy control tissues (n = 15), radicular cysts (RCs, n = 11), and periapical granulomas (PG, n = 13), were examined. Tissues were fixed in paraformaldehyde and analyzed. The inflammatory infiltrates of lesions were evaluated by hematoxylin-eosin, and the expression of IRF8 was analyzed by immunohistochemistry. Double immunofluorescence assessment was performed to colocalize IRF8 with CD68, NF-κB p65, and LC3B. RESULTS: The expression of IRF8 was significantly higher in RCs and PGs than in the healthy control group, but no significant difference was found between RCs and PGs. There were significantly more IRF8-CD68 double-positive cells in RCs and PGs than in the healthy control group, but no significant difference was observed between RCs and PGs. Double-labeling analysis of IRF8 with NF-κB and LC3B indicated that IRF8 expression is associated with NF-κB signaling and the autophagy process during periapical lesions. CONCLUSIONS: IRF8 could be observed and might possibly be involved in macrophages in the development of periapical lesions.


Subject(s)
Interferon Regulatory Factors/metabolism , Periapical Diseases/metabolism , Periapical Tissue/metabolism , Adult , Case-Control Studies , Female , Fluorescent Antibody Technique , Humans , Macrophages/metabolism , Male , Middle Aged , NF-kappa B/metabolism , Periapical Diseases/pathology , Periapical Granuloma/metabolism , Periapical Granuloma/pathology , Periapical Tissue/pathology , Radicular Cyst/metabolism , Radicular Cyst/pathology , Young Adult
9.
J Endod ; 43(5): 766-773, 2017 May.
Article in English | MEDLINE | ID: mdl-28292604

ABSTRACT

INTRODUCTION: Mineral trioxide aggregate (MTA) regulates bone remodeling, particularly osteoclast differentiation. However, intracellular mechanisms underlying the anti-osteoclastogenesis of MTA remain unclear. This study aimed to evaluate the potential alterations of autophagic pathway during anti-osteoclastogenic effects by MTA in vitro and investigate their underlying mechanisms. METHODS: Osteoclast precursors were treated with MTA extracts containing the receptor activator of nuclear factor-kappa B ligand (RANKL). Rapamycin was used to activate autophagy. RANKL-induced osteoclast differentiation was stained with tartrate-resistant acid phosphatase. Several specific autophagy features in osteoclast precursors were measured by using immunofluorescence, monodansylcadaverine, and transmission electron microscope. Autophagy-related proteins were investigated via Western blot analysis. The mRNA expression involved in autophagic and osteoclastic activities was detected with quantitative real-time polymerase chain reaction. RESULTS: MTA extracts inhibited osteoclast differentiation via preventing the fusion of osteoclast precursors without cytotoxicity. MTA extracts interrupted RANKL-induced acidic vesicular organelle formation and autophagic vacuole appearance in osteoclast precursors. Moreover, autophagic genes and proteins stimulated with RANKL diminished with MTA extracts. Notably, autophagy activation through rapamycin promoted multinucleated osteoclasts formation and increased osteoclastic genes expression, which almost reversed MTA-mediated anti-osteoclastogenic effects. CONCLUSIONS: MTA inhibited osteoclastogenesis for bone repair through attenuating the autophagic pathway.


Subject(s)
Aluminum Compounds/pharmacology , Autophagy/drug effects , Calcium Compounds/pharmacology , Osteogenesis/drug effects , Oxides/pharmacology , Silicates/pharmacology , Africa, Western , Animals , Drug Combinations , Fluorescent Antibody Technique , Mice , Microscopy, Electron, Transmission , Osteoclasts/drug effects , RANK Ligand/pharmacology , RAW 264.7 Cells/drug effects , Real-Time Polymerase Chain Reaction , Sirolimus/pharmacology
10.
Toxicol Sci ; 157(1): 100-111, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28184909

ABSTRACT

2-hydroxyethyl methacrylate (HEMA) is the major resin monomer that is released from incomplete polymerized dental restorative and adhesive biomaterials during dental therapy. Autophagy and apoptosis are biologically connected and the relationship between autophagy and apoptosis is complex under various circumstances. This study aimed to determine whether autophagy is activated by HEMA and further explore the function of autophagy during the HEMA-induced apoptosis of dental mesenchymal cells (DMCs). We exposed DMCs to different concentrations of HEMA. Cell viability showed a time- and concentration-dependent decrease when exposed to HEMA. We showed that HEMA exposure increased autophagic vacuoles and the expression of autophagic biomarkers (Beclin1, Atg5 and LC3). Pre-incubated with autophagy inhibitors (3-methyladenine and chloroquine) significantly prevented HEMA-induced apoptosis. Interestingly, HEMA initiated nuclear factor-κB (NF-κB) expression and nuclear translocation, whereas the NF-κB inhibitor (Bay 11-7082) markedly suppressed HEMA-induced autophagic activation and apoptosis. As is consistent with the in vitro results, HEMA treatment resulted in dental pulp tissue toxicity and activation of typical autophagic vacuoles in the tooth slice organ culture model ex vivo. In summary, we demonstrated that NF-κB signaling functioned upstream of HEMA-inducecd autophagy in DMCs and that the activation of NF-κB-autophagy axis was responsible for HEMA-induced apoptosis. Our findings provide novel insights into the mechanisms of resin monomer-mediated dental pulp damage during dental treatment, highlighting the activation of NF-κB-autophagy axis as an important mechanism of HEMA-mediated apoptosis.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Mesenchymal Stem Cells/drug effects , Methacrylates/toxicity , Tooth/cytology , Adolescent , Adult , Beclin-1/metabolism , Cells, Cultured , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , NF-kappa B/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...